Selenium supplementation decreases the pro-oxidant and cardiotoxicity effects of adriamycin in the rat

Redox Report

Volumn 2, Issue 5, 1996, Pages 323-332

  Coudray, C ^a   Boucher, F ^b   Hida, H ^c   Tirard, V ^b   De Leiris, J ^b   Favier, A ^a,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b CNRS   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000409122     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1080/13510002.1996.11747068     Document Type: Article

References (29)

1. Di Marco A, Gaetani M, Scarpinato B. Adriamycin: a new antibiotic with antitumor properties. Cancer Chemother Rep 1969; 53: 33-38.
2. Niwa N, Kanaide H, Meno H, Nakamura M. Adriamycin and altered membrane functions in rat hearts. Br J Exp Path 1986; 67: 747-755.
3. Bachur N R, Gordon S L, Gee M V. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 1978; 38: 1745-1750.
4. Keizer H G, Pinedo H M, Schuurhuis G J, Joenje H. Doxorubicin (Adriamycin): A critical review of free radical-dependent mechanisms of cytotoxicity. Pharmac Ther 1990; 47: 219-231.
5. Facchinetti T, Delaini F, Salmona M, Donati M B, Feuerstein S, Wendel A. The influence of selenium intake on chronic adriamycin toxicity and lipid peroxidation in rat. Toxicol Lett 1983; 15: 301-307.
6. Coudray C, Mouhieddine S, Richard M J, de Leiris J, Favier A. Effects of adriamycin on chronic cardiotoxicity in Se-deficient rats. Basic Res Cardiol 1992; 87: 173-183.
7. Myers C E, McGuire W, Young R. Adriamycin: Amelioration of toxicity by α-tocopherol. Cancer Treat Rep 1976; 60: 961-962.
8. Powell S R, McCay P B. Inhibition of doxorubicin-initiated membrane damage by N-acetylcysteine; possible mediation by a thiol-dependent cytosolic inihibitor of lipid peroxidation. Toxicol Appl Pharmacol 1988; 96: 175-184.
9. Lenzhofer R, Magometschnigg D, Dudczak R, Cernie C, Bolebruch C, Moser K. Indication of reduced doxorubicin-induced cardiac toxicity by additional treatment with antioxidant substances. Experientia 1983; 39: 62-64.
10. Mikae-Devie M, Ferenec D, Tiefenbach A. Serum selenium levels in untreated children with acute lymphoblastic leukemia I. J Trace Elem Electrolytes Health Dis 1990; 4: 7-10.
11. Gromadzinska J, Wasowicz W, Sklodowska M, Perek D, Popadiuk S. Glutathione peroxidase activity, selenium and lipid peroxide levels in blood of cancer children. Ann Clin Res 1989; 20: 177-183.
12. Revis N W, Marusic N. Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. J Mol Cell Cardiol 1977; 10: 945-951.
13. Ducros V, Favier A. Gas chromatographic-mass spectrometric method for the determination of selenium in biological samples. J Chromatogr 1992; 583: 35-44.
14. Gunzler W A, Kremers H, Flohé L. An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9) in blood. Z Klin Chem Klin Biochem 1974; 10: 444-448.
15. Marklund S L. Spectrophotometric study of spontaneous disproportionation of superoxide anion radical and sensitive direct assay for superoxide dismutase. J Biol Chem 1976; 251: 7504-7507.
16. Beers R F, Sizer I W. A Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952; 195: 133-135.
17. Richard M J, Guiaud P, Meo J, Favier A. High-performance liquid chromatographic separation of malondialdehydethiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. J Chromatogr 1992; 577: 9-18.
18. Desai I D. Vitamin E analysis methods for animal tissues. Meth Enzymol 1984; 105: 138-147.
19. Speek A J, Schrijver J, Schreurs W H P. Fluorometric determination of total vitamin C in whole blood by high-performance liquid chromatography with pre-column derivatisation. J Chromatogr 1984; 305: 53-60.
20. Lowry O H, Rosebrough N J, Farr A L, Randall R J. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
21. Sonneveld P. Effect of α-tocopherol on the cardiotoxicity of adriamycin in the rat. Cancer Treat Rep 1978; 62: 1033-1036.
22. Mettler P, Young D M, Ward J M. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Cancer Res 1977; 37: 2705-2713.
23. Montali U, Del Tacca M, Bernardini C, Segnini D, Solaini G. Cardiotoxic effects of adriamycin and mitochondrial oxidation in rat cardiac tissue. Drugs Exp Clin Res 1985; 11: 219-222.
24. Bertelli R, Ginevri F, Gusmano R, Ghiggeri G M. Cytotoxic effect of adriamycin and agarose-coupled adriamycin on glomerular epithelial cells; role of free radicals. In Vitro Cell Dev Biol 1991; 27A: 799-804.
25. Deffie A M, Batra I K, Goldberg G I. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and resistant P388 leukemia cell lines. Cancer Res 1989; 49: 58-62.
26. Buc-Calderon P, Praet M, Ruysschaert J M, Roberfroid M. Reduction of toxicity and increase of antitumor effect of Adriamycin by N-acyl-dehydroalanines, a new family of free radical scavengers. Adv Exp Med Biol 1990; 264: 339-344.
27. Legha S S, Wang Y-M, MacKay B, Ewer M, Hortobagyi G N. Clinical and pharmacologic investigation of the effects of α-tocopherol on adriamycin cardiotoxicity. Ann N Y Acad Sci 1982; 411-418.
28. Koller L D, Exon J H. The two faces of selenium: Deficiency and toxicity are similar in animals and man. Can J Vet Res 1986; 50: 297-306.
29. Konz K H, Haap M, Walsh R A, Burk R F, Seipel L. Selenium as a protector of diastolic function during oxidant stress. J Trace Elem Electrolytes Health Dis 1991; 5: 87-93.